Effectiveness of Upadacitinib for Inflammatory Bowel Disease Patients With Pouchitis: Prospective Real-World Experience

被引：0
|
作者：
Cleveland, Noa Krugliak [1 ]
Choi, Natalie [1 ]
Choi, David K. [1 ]
Dalal, Sushila [1 ]
Rubin, David T. [1 ]
机构：
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1141
引用
收藏
页码：S873 / S874
页数：2
相关论文
共 50 条
  • [41] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Brian Bressler
    Jennifer Jones
    Tracy S. H. In
    Tommy Lan
    Cristian Iconaru
    John K. Marshall
    Advances in Therapy, 2023, 40 : 4421 - 4439
  • [42] Real-world efficacy and safety of Upadacitinib in IBD patients. Preliminary data from the Apulian Network for Inflammatory Bowel Disease (AN-IBD)
    Bossa, F.
    Principi, M. B.
    Marzo, M.
    Stasi, E.
    Mazzuoli, S.
    Pranzo, G.
    Sacco, R.
    Fanigliulo, L.
    Neve, V
    Tursi, A.
    Rizzi, M.
    Bringiotti, R.
    Bucci, A.
    Allegretta, L.
    Contaldo, A.
    Mastronardi, M.
    De Tullio, N.
    Hadad, Y.
    Annese, M.
    Delll'Aquila, P.
    Palmisano, C. M.
    Paiano, P.
    Facciorusso, A.
    Rima, R.
    Guglielmi, F. W.
    Sgarro, C.
    Perri, F.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1439 - i1439
  • [43] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Bressler, Brian
    Jones, Jennifer
    In, Tracy S. H.
    Lan, Tommy
    Iconaru, Cristian
    Marshall, John K.
    ADVANCES IN THERAPY, 2023, 40 (10) : 4421 - 4439
  • [44] Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey
    Burisch, Johan
    Hart, Ailsa
    Sturm, Andreas
    Rudolph, Christine
    Meadows, Rachael
    Jus, Anna
    Dawod, Fatima
    Patel, Haridarshan
    Armuzzi, Alessandro
    INFLAMMATORY BOWEL DISEASES, 2024, 31 (02) : 411 - 424
  • [45] Effectiveness and safety of ustekinumab in patients with Crohn's disease: a real-world experience
    Mohammad, D.
    Alshahrani, A.
    Bao, Y.
    Alramdan, R.
    Rajani, A.
    Chauhan, U.
    Salena, B.
    Tse, F.
    Greenwald, E.
    Albashir, S.
    Halder, S.
    Armstrong, D.
    Marshall, J.
    Narula, N.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S426 - S426
  • [46] Effectiveness of switching from intravenous to subcutaneous infliximab in Inflammatory Bowel Disease patients: A combined analysis of real-world evidence
    Cummings, F.
    Buisson, A.
    Smith, P. J.
    Rahmany, S.
    Subramanian, S.
    Kwon, B.
    Park, S.
    Lee, Y. N.
    Fumery, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1332 - I1333
  • [47] EFFECTIVENESS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS: A COMBINED ANALYSIS OF REAL-WORLD EVIDENCE
    Cummings, Fraser
    Buisson, Anthony
    Smith, Philip J.
    Rahmany, Sohail
    Subramanian, Sreedhar
    Kwon, Buki
    Park, Soyeon
    Lee, Young Nam
    Fumery, Mathurin
    GASTROENTEROLOGY, 2024, 166 (05) : S1144 - S1144
  • [48] Effectiveness and safety of thiopurines in inflammatory bowel disease patients with NUDT15 polymorphism: a real-world retrospective study
    Chatterjee, Abhirup
    Bhatia, Prateek
    Sinha, Saroj K.
    Singh, Anupam K.
    Mandavdhare, Harshal S.
    Shah, Jimil
    Jearth, Vaneet
    Sasani, Arpit
    Sekar, Aravind
    Singh, Minu
    Dutta, Usha
    Sharma, Vishal
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2025, 18 (03) : 175 - 183
  • [49] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S74 - S75
  • [50] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (03) : S101 - S102
12345